erector spinae plane block for analgesia in pilonidal sinus surgery
Phase 3
Recruiting
- Conditions
- SurgeryAnaesthesia
- Registration Number
- PACTR201912565389988
- Lead Sponsor
- Dr Mona Elghamry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
seventy patients aged 20-60 years old
both sex
ASA class I and II
eligible for pilonidal sinus surgery
Exclusion Criteria
patient's refusal
pre-existing neurological or psychiatric illness
mental retardation
BMI >35 kg/m2
Allergy to local anesthetics
Infection at the injection site
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the analgesic effects of erector spinae plane blocks in postoperative pain management?
How does ultrasound guided sacral erector spinae plane block compare to traditional epidural analgesia in pilonidal sinus surgery outcomes?
Are there specific biomarkers that predict optimal response to erector spinae plane block in surgical patients?
What adverse events are associated with sacral erector spinae plane block and how are they managed clinically?
How do combination approaches of erector spinae plane block with local anesthetics enhance postoperative pain control in complex surgeries?